Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

Clinical trial NCT00443196 · COMPLETED

Trial details

NCT number: NCT00443196
Sponsor: Pierian Biosciences
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Adenocarcinoma Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms

Start date: 2006-03-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.